MYNX

What is MYNX?

MYNX is a vascular closure device (VCD) used to close punctures in blood vessels after catheter-based procedures like angioplasty or other endovascular interventions. It helps achieve rapid hemostasis, allowing patients to move around sooner. MYNX is available in various sizes to fit different vessel diameters and access sites.

Benefits

MYNX offers several key advantages:

• Rapid Hemostasis: MYNX quickly seals puncture sites, reducing the time it takes for bleeding to stop.
• Early Ambulation: Patients can move around sooner after the procedure, improving their recovery experience.
• Biocompatible and Biodegradable: The device uses materials like polyethylene glycol (PEG) that are safe and break down naturally in the body.
• Easy to Use: MYNX is designed for quick deployment, making it efficient for healthcare providers to use, especially in busy clinical settings.
• Low Complication Rates: MYNX has been shown to have a low rate of complications such as hematoma or infection.

Use Cases

MYNX is used in various clinical settings, including:

• Femoral Access Sites: Commonly used for procedures involving the femoral artery.
• Radial Access Sites: Increasingly used for procedures involving the radial artery.
• Catheter-Based Procedures: Such as angioplasty and other endovascular interventions.

Additional Information

MYNX is approved by the U.S. Food and Drug Administration (FDA) and is widely used in clinical practice. The device's design ensures it is easy to use and can be deployed rapidly, allowing for efficient patient turnover in busy clinical settings. MYNX's biocompatible and biodegradable nature reduces the risk of adverse reactions or long-term complications.